“Eliminating insurance for generics might make patients nervous at first, but the payoff would be stable and affordable prices.” Fascinating perspective on a disruptive idea from @erinetrish and @KarenVanNuys. Similar themes I’ve heard discussed by @PopovianPharmD.
“Eliminating insurance for generics might make patients nervous at first, but the payoff would be stable and affordable prices.” Fascinating perspective on a disruptive idea from @erinetrish and @KarenVanNuys. Similar themes I’ve heard discussed by @PopovianPharmD.
@A_Ciaccia @erinetrish @KarenVanNuys @PopovianPharmD Or just have them be one of the growing number of insurance companies working with @costplusdrugs. Same price as patients would pay to us, with no patient OOP . The best of both worlds. Our partnership with @capbluecross has saved their plan holders a ton of $$
@mcuban @A_Ciaccia @erinetrish @KarenVanNuys @PopovianPharmD @costplusdrugs @capbluecross Don’t care, tank the season and get the top 10 pick
@mcuban @A_Ciaccia @erinetrish @KarenVanNuys @PopovianPharmD @costplusdrugs @capbluecross Mark, any upcoming PBM/DIR reform coming through the pipeline we should be aware of? What can we do as the general public to get involved and make some waves for change?